NDC 0603-2129 is a in the category. It is labeled and distributed by .
Proprietary Name | NDC 0603-2129 |
Marketing Category | / |
Marketing Category | ANDA |
Application Number | ANDA078491 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-09-25 |
Marketing End Date | 2016-10-31 |
Marketing Category | ANDA |
Application Number | ANDA078491 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-09-25 |
Marketing End Date | 2016-10-31 |
Marketing Category | ANDA |
Application Number | ANDA078491 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-09-25 |
Marketing End Date | 2016-10-31 |
Marketing Category | ANDA |
Application Number | ANDA078491 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-09-25 |
Marketing End Date | 2016-10-31 |
Marketing Category | ANDA |
Application Number | ANDA078491 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-09-25 |
Marketing End Date | 2016-10-31 |
Marketing Category | ANDA |
Application Number | ANDA078491 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-09-25 |
Marketing End Date | 2016-10-31 |
Marketing Category | ANDA |
Application Number | ANDA078491 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-09-25 |
Marketing End Date | 2016-10-31 |
Marketing Category | ANDA |
Application Number | ANDA078491 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-09-25 |
Marketing End Date | 2016-10-31 |